Clinical Trials Browser

Phase 2 × Prostatic Neoplasms × figitumumab × Clear all

NCT00313781 2013-04-11

Study of CP-751,871 in Combination With Docetaxel and Prednisone in Patients With Hormone Insensitive Prostate Cancer (HRPC)

Phase 2 Completed

204 enrolled 12 charts

Prostatic Neoplasms